Yantai Zhenghai Biotechnology Future Growth
Future criteria checks 3/6
Yantai Zhenghai Biotechnology is forecast to grow earnings and revenue by 15% and 14.7% per annum respectively. EPS is expected to grow by 15.1% per annum. Return on equity is forecast to be 20.3% in 3 years.
Key information
15.0%
Earnings growth rate
15.1%
EPS growth rate
Biotechs earnings growth | 43.4% |
Revenue growth rate | 14.7% |
Future return on equity | 20.3% |
Analyst coverage | Low |
Last updated | 30 Oct 2024 |
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 535 | 235 | N/A | 241 | 1 |
12/31/2025 | 455 | 196 | N/A | 208 | 2 |
12/31/2024 | 397 | 171 | N/A | 191 | 2 |
9/30/2024 | 383 | 168 | 161 | 175 | N/A |
6/30/2024 | 387 | 167 | 143 | 174 | N/A |
3/31/2024 | 394 | 178 | 135 | 165 | N/A |
12/31/2023 | 414 | 191 | 149 | 180 | N/A |
9/30/2023 | 414 | 178 | 135 | 166 | N/A |
6/30/2023 | 426 | 191 | 122 | 168 | N/A |
3/31/2023 | 425 | 184 | 128 | 175 | N/A |
1/1/2023 | 433 | 185 | 132 | 188 | N/A |
9/30/2022 | 440 | 197 | 139 | 179 | N/A |
6/30/2022 | 431 | 192 | 179 | 192 | N/A |
3/31/2022 | 416 | 180 | 190 | 193 | N/A |
12/31/2021 | 400 | 169 | 156 | 166 | N/A |
9/30/2021 | 378 | 149 | 109 | 171 | N/A |
6/30/2021 | 360 | 144 | 69 | 150 | N/A |
3/31/2021 | 351 | 143 | 38 | 143 | N/A |
12/31/2020 | 293 | 118 | 15 | 118 | N/A |
9/30/2020 | 295 | 123 | 35 | 115 | N/A |
6/30/2020 | 282 | 111 | 50 | 115 | N/A |
3/31/2020 | 263 | 100 | 28 | 91 | N/A |
12/31/2019 | 280 | 107 | 41 | 103 | N/A |
9/30/2019 | 251 | 100 | 44 | 91 | N/A |
6/30/2019 | 243 | 97 | 46 | 83 | N/A |
3/31/2019 | 230 | 91 | 61 | 84 | N/A |
12/31/2018 | 216 | 86 | 71 | 77 | N/A |
9/30/2018 | 216 | 88 | 71 | 77 | N/A |
6/30/2018 | 204 | 81 | N/A | 77 | N/A |
3/31/2018 | 193 | 76 | N/A | 76 | N/A |
12/31/2017 | 183 | 62 | N/A | 65 | N/A |
9/30/2017 | 176 | 54 | N/A | 68 | N/A |
6/30/2017 | 164 | 47 | N/A | 60 | N/A |
3/31/2017 | 159 | 46 | N/A | 56 | N/A |
12/31/2016 | 151 | 45 | N/A | 49 | N/A |
6/30/2016 | 138 | 43 | N/A | 45 | N/A |
3/31/2016 | 126 | 41 | N/A | 41 | N/A |
12/31/2015 | 128 | 42 | N/A | 46 | N/A |
12/31/2014 | 105 | 34 | N/A | 31 | N/A |
12/31/2013 | 77 | 16 | N/A | 34 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 300653's forecast earnings growth (15% per year) is above the savings rate (2.8%).
Earnings vs Market: 300653's earnings (15% per year) are forecast to grow slower than the CN market (26.2% per year).
High Growth Earnings: 300653's earnings are forecast to grow, but not significantly.
Revenue vs Market: 300653's revenue (14.7% per year) is forecast to grow faster than the CN market (13.8% per year).
High Growth Revenue: 300653's revenue (14.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 300653's Return on Equity is forecast to be high in 3 years time (20.3%)